Oxford Cancer Analytics

Oxford Cancer Analytics is a biotechnology company developing blood-based diagnostic tests for early cancer detection using high-throughput circulating proteome analysis and machine learning.

Its platform identifies protein biomarker signatures from blood samples to support clinical decision-making in lung disease, with initial applications in lung cancer and chronic obstructive pulmonary disease.

The approach is designed to be minimally invasive, affordable, and deployable at population scale as an alternative to imaging and tissue biopsy.